1. FDA US DEPARTMENT OF HEALTH AND HUMAN SERVICES: Code of Federal Regulations, Title 21, Subchapter D Drugs for Human Use, part 320 Bioavailability and Bioequivalence Requirements.
2. FDA US DEPARTMENT OF HEALTH AND HUMAN SERVICES: CDER, Waiver ofinvivobioavailability and bioequivalence studies for immediate-release solid oral dosage forms based on a biopharmaceuticals classification system.
3. Nonlinear assessment of phenytoin bioavailability